Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,200
Closed -$9.37M 3933
2021
Q4
$9.37M Sell
20,200
-1,500
-7% -$664K 0.01% 1556
2021
Q3
$8.45M Buy
21,700
+6,800
+46% +$2.89M ﹤0.01% 1658
2021
Q2
$6.59M Buy
14,900
+14,300
+2,383% +$6.25M ﹤0.01% 1860
2021
Q1
$252K Buy
+600
New +$240K ﹤0.01% 4051
2017
Q1
Sell
-32,500
Closed -$6.63M 3912
2016
Q4
$6.63M Sell
32,500
-10,000
-24% -$1.91M 0.01% 1459
2016
Q3
$7.52M Buy
+42,500
New +$7.38M 0.01% 1368
2015
Q3
Sell
-5,000
Closed -$956K 4362
2015
Q2
$956K Hold
5,000
﹤0.01% 3227
2015
Q1
$890K Buy
+5,000
New +$791K ﹤0.01% 3069

Other funds holding HUM

Credit Suisse's HUM Position: Q1 2024 in Review

Credit Suisse reduced its Humana (HUM) stake by 6.8% in Q1 2024, selling an estimated $6.32M and leaving 230,358 shares worth $79.9M. The position accounts for 0.08% of the portfolio, ranked #259.

Credit Suisse first reported a position in HUM in Q2 2013 and has held it in 44 quarters since. The position peaked at $147M in Q1 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Credit Suisse held 230,358 shares of Humana worth $79.9M as of Q1 2024.
  • Credit Suisse sold 16,676 Humana shares in Q1 2024, an estimated $6.32M.
  • Humana made up 0.08% of Credit Suisse's portfolio in Q1 2024, its #259 holding.
  • Credit Suisse first reported a position in Humana in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Humana position peaked at $147M in Q1 2023.
  • 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.